Gastroenteropancreatic neuroendocrine tumors (NETs) have an incidence of 2.39 per 100,000 inhabitants per year, and a prevalence of 35 cases per 100,000 inhabitants; the gap between these rates is due to the relatively long survival time of these tumors, which can be thus considered as chronic oncological diseases. Recently, more therapeutic options have become available, but criteria for defining timing, priority and sequence of different therapeutic options are still debated. This review offers an overview of pancreatic and small bowel NETs, critically underlining the issues that still need to be clarified and some controversial issues on the therapeutic approach for NET patients.
Controversies in the treatment of digestive neuroendocrine tumors / Rinzivillo, Maria; Panzuto, Francesco; DELLE FAVE, Gianfranco. - In: JOURNAL OF CANCER METASTASIS AND TREATMENT. - ISSN 2394-4722. - 2:(2016), pp. 304-309. [10.20517/2394-4722.2016.40]
Controversies in the treatment of digestive neuroendocrine tumors
Maria Rinzivillo;Francesco Panzuto;Gianfranco Delle Fave
2016
Abstract
Gastroenteropancreatic neuroendocrine tumors (NETs) have an incidence of 2.39 per 100,000 inhabitants per year, and a prevalence of 35 cases per 100,000 inhabitants; the gap between these rates is due to the relatively long survival time of these tumors, which can be thus considered as chronic oncological diseases. Recently, more therapeutic options have become available, but criteria for defining timing, priority and sequence of different therapeutic options are still debated. This review offers an overview of pancreatic and small bowel NETs, critically underlining the issues that still need to be clarified and some controversial issues on the therapeutic approach for NET patients.File | Dimensione | Formato | |
---|---|---|---|
Rinzivillo_Controversies_2016.pdf
accesso aperto
Note: review
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
905.99 kB
Formato
Adobe PDF
|
905.99 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.